Yvette Latchman
About Yvette Latchman
Yvette Latchman: Sr. Director, Discovery Research
Yvette Latchman holds the title of Senior Director of Discovery Research. In this role, she leads research initiatives focused on immunology and immune-related diseases. Her expertise includes areas such as immuno-oncology, inflammation, vaccines, autoimmunity, and drug discovery.
Yvette Latchman's Expertise in Immunology and Autoimmunity
Yvette Latchman has extensive experience in fundamental immunology and immune-related diseases. Her areas of expertise encompass immuno-oncology, inflammation, vaccines, autoimmunity, and drug discovery. She has a strong background in designing and implementing pre-clinical in vivo immunology studies, contributing significantly to advancements in understanding and treating these conditions.
Professional Background: Silverback Therapeutics and ImmunityBio
Yvette Latchman previously worked at Silverback Therapeutics, where she supervised biology aspects of several immune-oncology preclinical programs, focusing on antibody drug conjugate technologies. She also contributed to ImmunityBio, formerly known as Etubics, by designing and implementing pre-clinical in vivo immunology studies in mice for new vaccines based on the company's advanced viral vector platform.
Yvette Latchman's Academic Contributions: BloodWorks and University of Washington
Yvette Latchman served as an Assistant Member at BloodWorks and as an Adjunct Assistant Professor at the University of Washington. Her lab's research concentrated on PD-1 and innate cells in tumor immunity, enhancing the understanding of immune checkpoint pathways in oncology.
Yvette Latchman's Education in Immunology
Yvette Latchman received her PhD in Immunology from University College, London. Her doctoral research focused on the role of IgE complexes and the low affinity IgE receptor in atopic eczema. She also completed postdoctoral research and received a Wellcome Trust fellowship at Harvard Medical School and Brigham and Women’s Hospital, investigating the role of the PD-1 pathway in T cell activation and autoimmunity.